Lichen planus and lichenoid drug eruption after vaccination
- PMID: 29360907
Lichen planus and lichenoid drug eruption after vaccination
Abstract
Lichen planus (LP) and lichenoid drug eruptions (LDEs) uncommonly occur after vaccination, especially for hepatitis B and influenza. The key initiating event that leads to the development of postimmunization LP or LDE is not well understood. There have been prior reports of an association between several vaccines and LP. In this study, we aim to characterize and review cases of LP and LDE after vaccination from the Vaccine Adverse Event Reporting System (VAERS) national database in the United States. Information on vaccine-associated LP and LDE was retrieved from the database (July 1990 to November 2014) to examine the frequency of LP or LDE after vaccination. Hepatitis B, influenza, and herpes zoster vaccines were the 3 most commonly associated vaccines. Patients with LP or LDE were significantly older compared to the reported adverse events (AEs) overall (P<.001). The median age of onset for LP and LDE was 47 years. The median time of onset of AEs was 14 days. It is important to obtain recent vaccination history in patients presenting with new-onset LP or LDE.
Similar articles
-
Lichen planus and lichenoid drug-induced eruption: a histological and immunohistochemical study.Int J Dermatol. 2012 Oct;51(10):1199-205. doi: 10.1111/j.1365-4632.2011.05113.x. Epub 2012 Mar 14. Int J Dermatol. 2012. PMID: 22416968
-
Lichen planus following COVID-19 vaccination: a narrative review.Clin Exp Dermatol. 2025 Jan 27;50(2):260-266. doi: 10.1093/ced/llae356. Clin Exp Dermatol. 2025. PMID: 39187929 Review.
-
The new differential diagnostic test for the lichenoid drug eruption.Dermatol Ther. 2020 Nov;33(6):e13784. doi: 10.1111/dth.13784. Epub 2020 Jul 3. Dermatol Ther. 2020. PMID: 32510667
-
Expression of CD1 and HLA-DR by Langerhans cells (LC) in oral lichenoid drug eruptions (LDE) and idiopathic oral lichen planus (LP).J Oral Pathol Med. 1997 Apr;26(4):176-80. doi: 10.1111/j.1600-0714.1997.tb00454.x. J Oral Pathol Med. 1997. PMID: 9176792
-
Cutaneous lichenoid drug eruptions: A narrative review evaluating demographics, clinical features and culprit medications.J Eur Acad Dermatol Venereol. 2023 May;37(5):965-975. doi: 10.1111/jdv.18879. Epub 2023 Feb 4. J Eur Acad Dermatol Venereol. 2023. PMID: 36652271 Review.
Cited by
-
COVID-19 "second wave" and vaccines: the dermatologists' perspective.Int J Dermatol. 2021 Jul;60(7):889-890. doi: 10.1111/ijd.15547. Epub 2021 Mar 25. Int J Dermatol. 2021. PMID: 33763883 Free PMC article. No abstract available.
-
COVID-19 Vaccine-Induced Lichenoid Eruptions-Clinical and Histopathologic Spectrum in a Case Series of Fifteen Patients with Review of the Literature.Vaccines (Basel). 2023 Feb 14;11(2):438. doi: 10.3390/vaccines11020438. Vaccines (Basel). 2023. PMID: 36851315 Free PMC article.
-
New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination.J Cosmet Dermatol. 2022 Sep;21(9):3679-3681. doi: 10.1111/jocd.15185. Epub 2022 Jul 19. J Cosmet Dermatol. 2022. PMID: 35754299 Free PMC article. No abstract available.
-
Oral Lichen Planus: An Updated Review of Etiopathogenesis, Clinical Presentation, and Management.Indian Dermatol Online J. 2023 Dec 22;15(1):8-23. doi: 10.4103/idoj.idoj_652_22. eCollection 2024 Jan-Feb. Indian Dermatol Online J. 2023. PMID: 38283029 Free PMC article. Review.
-
Mucocutaneous lichenoid eruptions following COVID-19 vaccination: A keen observation.J Cosmet Dermatol. 2022 Sep;21(9):3689-3691. doi: 10.1111/jocd.15208. Epub 2022 Jul 19. J Cosmet Dermatol. 2022. PMID: 35778897 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical